Handelsbanken Fonder Ab Biotechnology

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
IOVA Iovance Biotherapeutics, Inc.	$1.17B	$702,000 0.0% of portfolio	74,800	Q3 2024 Added 18.17%
BEAM Beam Therapeutics Inc.	$1.91B	$698,000 0.0% of portfolio	28,500	Q3 2024 Added 61.93%
DYN Dyne Therapeutics, Inc.	$1.23B	$693,000 0.0% of portfolio	19,300	Q3 2024 Added 21.38%
ARWR Arrowhead Pharmaceuticals, Inc.	$2.08B	$692,000 0.0% of portfolio	35,700	Q3 2024 Added 17.05%
CPRX Catalyst Pharmaceuticals, Inc.	$2.01B	$685,000 0.0% of portfolio	34,477	Q3 2024 Added 18.98%
NTLA Intellia Therapeutics, Inc.	$948M	$666,000 0.0% of portfolio	32,400	Q3 2024 Added 24.14%
MLTX Moon Lake Immunotherapeutics	$1.85B	$655,000 0.0% of portfolio	13,000	Q3 2024 Added 26.21%
VCEL Vericel Corp	$2.74B	$654,000 0.0% of portfolio	15,479	Q3 2024 Added 24.04%
VERA Vera Therapeutics, Inc.	$1.14B	$610,000 0.0% of portfolio	13,800	Q3 2024 Added 18.97%
IMVT Immunovant, Inc.	$3.55B	$596,000 0.0% of portfolio	20,900	Q3 2024 Added 29.01%
AKRO Akero Therapeutics, Inc.	$1.24B	$574,000 0.0% of portfolio	20,000	Q3 2024 Added 12.36%
ACIU Ac Immune Sa	$244M	$567,000 0.0% of portfolio	150,000	Q1 2024 Added 48.42%
KROS Keros Therapeutics, Inc.	$408M	$563,000 0.0% of portfolio	9,700	Q3 2024 Added 21.25%
LGND Ligand Pharmaceuticals Inc	$1.86B	$536,000 0.0% of portfolio	5,358	Q3 2024 Added 10.29%
ARVN Arvinas, Inc.	$1.03B	$481,000 0.0% of portfolio	19,525	Q3 2024 Added 17.44%
CLDX Celldex Therapeutics, Inc.	$1.29B	$469,000 0.0% of portfolio	13,800	Q3 2024 Added 23.21%
XNCR Xencor Inc	$1.43B	$469,000 0.0% of portfolio	23,300	Q3 2024 Added 14.78%
RXRX Recursion Pharmaceuticals, Inc.	$1.35B	$458,000 0.0% of portfolio	69,500	Q3 2024 Added 33.4%
HRMY Harmony Biosciences Holdings, Inc.	$2.08B	$452,000 0.0% of portfolio	11,300	Q3 2024 Added 15.31%
AUPH Aurinia Pharmaceuticals Inc.	$1.19B	$445,000 0.0% of portfolio	60,700	Q3 2024 Added 13.25%
DAWN Day One Biopharmaceuticals, Inc.	$911M	$376,000 0.0% of portfolio	27,000	Q3 2024 Added 16.88%
MRVI Maravai Lifesciences Holdings, Inc.	$796M	$371,000 0.0% of portfolio	44,600	Q3 2024 Added 35.56%
RCUS Arcus Biosciences, Inc.	$1.1B	$341,000 0.0% of portfolio	22,300	Q3 2024 Added 15.54%
RCKT Rocket Pharmaceuticals, Inc.	$950M	$336,000 0.0% of portfolio	18,200	Q2 2024 Added 3.41%
PRTA Prothena Corp Public LTD CO	$664M	$258,000 0.0% of portfolio	15,400	Q2 2024 Added 63.83%
AUTL Autolus Therapeutics PLC	$229M	$203,000 0.0% of portfolio	56,000	Q2 2024 New
IBRX Immunity Bio, Inc.	$1.09B	$201,000 0.0% of portfolio	53,900	Q2 2024 New
VIR Vir Biotechnology, Inc.	$1.05B	$198,000 0.0% of portfolio	26,400	Q2 2024 Added 17.33%
ABCL Ab Cellera Biologics Inc.	$935M	$182,000 0.0% of portfolio	69,900	Q2 2024 Added 16.11%
ZNTL Zentalis Pharmaceuticals, Inc.	$170M	$79,000 0.0% of portfolio	21,500	Q2 2024 Added 59.26%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.